{
    "clinical_study": {
        "@rank": "84221", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Quantify periodontal alveolar bone loss rates in postmenopausal women.\n\n      II.  Evaluate the effects of estrogen on alveolar bone loss rates in these patients.\n\n      III.  Determine whether changes in periodontal bone mass relate to bone mass changes in\n      other skeletal sites in these patients."
        }, 
        "brief_title": "Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss", 
        "condition": "Osteoporosis", 
        "condition_browse": {
            "mesh_term": [
                "Alveolar Bone Loss", 
                "Osteoporosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized, double-blind, placebo controlled study. Patients are\n      randomly assigned to receive placebo or conjugated estrogens and, if no prior hysterectomy,\n      medroxyprogesterone.  Patients also receive calcium supplementation therapy daily for 3\n      years.\n\n      Participants in the placebo group may be removed from study if bone loss exceeds 5% per\n      year.\n\n      A study duration of 3 years is anticipated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n          -  Women postmenopausal for at least 2 years\n\n          -  At least 10 teeth for which radiographic measurements can be obtained, i.e.: Not\n             severely tilted Not so closely spaced that interproximal bone is thin Not in\n             positions of restricted access"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "150", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004650", 
            "org_study_id": "199/11726", 
            "secondary_id": "WUSM-900449"
        }, 
        "intervention": [
            {
                "intervention_name": "conjugated estrogens", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Medroxyprogesterone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Estrogens, Conjugated (USP)", 
                "Estrogens", 
                "Medroxyprogesterone", 
                "Medroxyprogesterone Acetate"
            ]
        }, 
        "keyword": [
            "disease-related problem/condition", 
            "osteoporosis", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Charles F. Hildebolt", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "reference": [
            {
                "PMID": "9401935", 
                "citation": "Hildebolt CF, Pilgram TK, Dotson M, Yokoyama-Crothers N, Muckerman J, Hauser J, Cohen S, Kardaris E, Vannier MW, Hanes P, Shrout MK, Civitelli R. Attachment loss with postmenopausal age and smoking. J Periodontal Res. 1997 Oct;32(7):619-25."
            }, 
            {
                "PMID": "9446984", 
                "citation": "Hildebolt CF. Osteoporosis and oral bone loss. Dentomaxillofac Radiol. 1997 Jan;26(1):3-15. Review."
            }, 
            {
                "PMID": "9780904", 
                "citation": "Hildebolt CF, Brunsden B, Yokoyama-Crothers N, Pilgram TK, Townsend KE, Vannier MW, Shrout MK. Comparison of reliability of manual and computer-intensive methods for radiodensity measures of alveolar bone loss. Dentomaxillofac Radiol. 1998 Jul;27(4):245-50."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004650"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Dental and Craniofacial Research (NIDCR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "August 1993", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 1999"
    }, 
    "geocoordinates": {}
}